Biotech giant Gilead Sciences, Inc. GILD has put up a steady performance in 2024 amid a volatile market. Its shares have ...

* EPS estimates are Normalized unless otherwise noted.

The purchases were made Tuesday through Thursday. The Occidental Petroleum buy was the first since June, suggesting Berkshire ...

This growth, in large part driven by tech and the continuing AI revolution, has surprised value investors and professional ...

Xilio Therapeutics (Nasdaq: XLO) is making significant strides in the world of immuno-oncology, with a focus on tumor-activated therapies that target cancer while minimizing the side effects often ...

In a report released yesterday, Courtney Breen from Bernstein maintained a Buy rating on Eli Lilly & Co (LLY – Research Report), with a ...

H.C. Wainwright lowered the firm’s price target on Prothena (PRTA) to $48 from $84 and keeps a Buy rating on the shares after the Phase 2b ...

Kohl's Corp.-0.07% $1.54B ...

U.S. Bancorp Dep. Pfd. (Rep. 1/1000th Non-Cum. Perp. Pfd. Series K)-0.79% U.S. Bancorp Dep. Pfd. (Rep. 1/1000th Perp. 3.75% Pfd. Series L)-0.87% U.S. Bancorp Dep. Pfd ...

Stocks: Real-time U.S. stock quotes reflect trades reported through ... Sources: FactSet, Tullett Prebon Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange ...

Chip company Nvidia gets the green light from the European Union to complete its acquisition of Run:ai. The EU came to a unanimous decision today that Nvidia could go ahead with its acquisition of ...